These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32371328)

  • 1. Pretreatment and non-specific binding in ultrafiltration device: Impact on protease inhibitor quantification.
    Castro TNE; Costa ER; Gonçalves JCS; Estrela RCE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1146():122127. PubMed ID: 32371328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography-tandem mass spectrometry and ultrafiltration methods.
    Illamola SM; Labat L; Benaboud S; Tubiana R; Warszawski J; Tréluyer JM; Hirt D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():216-23. PubMed ID: 25049210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lopinavir protein binding in vivo through the 12-hour dosing interval.
    Boffito M; Hoggard PG; Lindup WE; Bonora S; Sinicco A; Khoo SH; Di Perri G; Back DJ
    Ther Drug Monit; 2004 Feb; 26(1):35-9. PubMed ID: 14749547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of nonspecific binding in ultrafiltration protein binding studies.
    Lee KJ; Mower R; Hollenbeck T; Castelo J; Johnson N; Gordon P; Sinko PJ; Holme K; Lee YH
    Pharm Res; 2003 Jul; 20(7):1015-21. PubMed ID: 12880287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitation of HIV-protease inhibitors ritonavir, lopinavir and indinavir in human plasma by UPLC-ESI-MS-MS.
    Das Mishra T; Kurani H; Singhal P; Shrivastav PS
    J Chromatogr Sci; 2012 Aug; 50(7):625-35. PubMed ID: 22562821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay.
    Ehrhardt M; Möck M; Haefeli WE; Mikus G; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):249-58. PubMed ID: 17161668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography/tandem mass spectrometry detection.
    Estrela RC; Ribeiro FS; Seixas BV; Suarez-Kurtz G
    Rapid Commun Mass Spectrom; 2008; 22(5):657-64. PubMed ID: 18257112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC-MS/MS assay and ultrafiltration method.
    Arellano C; Gandia P; Lafont T; Jongejan R; Chatelut E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():94-100. PubMed ID: 23000741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of amprenavir total and unbound concentrations in plasma by high-performance liquid chromatography and ultrafiltration.
    Barrail A; Le Tiec C; Paci-Bonaventure S; Furlan V; Vincent I; Taburet AM
    Ther Drug Monit; 2006 Feb; 28(1):89-94. PubMed ID: 16418700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC-ESI-MS/MS for bioequivalence study in Indian subjects.
    Yadav M; Rao R; Kurani H; Singhal P; Goswami S; Shrivastav PS
    J Pharm Biomed Anal; 2009 May; 49(4):1115-22. PubMed ID: 19282124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of lopinavir and ritonavir in human plasma by high performance liquid chromatography coupled with UV detection.
    Kou H; Ye M; Fu Q; Han Y; Du X; Xie J; Zhu Z; Li T
    Sci China Life Sci; 2012 Apr; 55(4):321-7. PubMed ID: 22566088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavir.
    Mo H; Lu L; Dekhtyar T; Stewart KD; Sun E; Kempf DJ; Molla A
    Antiviral Res; 2003 Aug; 59(3):173-80. PubMed ID: 12927307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry.
    DiFrancesco R; DiCenzo R; Vicente G; Donnelly J; Martin TM; Colon LA; Schifito G; Morse GD
    J Pharm Biomed Anal; 2007 Sep; 44(5):1139-46. PubMed ID: 17601694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir Active pharmaceutical ingredients by LC/MS/MS using electrospray ionization.
    Kakadiya PR; Reddy BP; Singh V; Ganguly S; Chandrashekhar TG; Singh DK
    J Pharm Biomed Anal; 2011 May; 55(2):379-84. PubMed ID: 21353429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway.
    Taura M; Kariya R; Kudo E; Goto H; Iwawaki T; Amano M; Suico MA; Kai H; Mitsuya H; Okada S
    Free Radic Biol Med; 2013 Dec; 65():778-788. PubMed ID: 23973637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritonavir-boosted atazanavir-lopinavir combination: a pharmacokinetic interaction study of total, unbound plasma and cellular exposures.
    Colombo S; Buclin T; Franc C; Guignard N; Khonkarly M; Tarr PE; Rochat B; Biollaz J; Telenti A; Decosterd LA; Cavassini M
    Antivir Ther; 2006; 11(1):53-62. PubMed ID: 16518960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir.
    Hickman D; Vasavanonda S; Nequist G; Colletti L; Kati WM; Bertz R; Hsu A; Kempf DJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2911-7. PubMed ID: 15273100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS.
    Notari S; Sergi M; Montesano C; Ivanovic J; Narciso P; Pucillo LP; Ascenzi P
    IUBMB Life; 2012 May; 64(5):443-9. PubMed ID: 22473795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.
    Wang C; Williams NS
    J Pharm Biomed Anal; 2013 Mar; 75():112-7. PubMed ID: 23312388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay.
    Thongkum W; Hadpech S; Tawon Y; Cressey TR; Tayapiwatana C
    Anal Chim Acta; 2019 Sep; 1071():86-97. PubMed ID: 31128760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.